Industry Insights: Regulatory wrangles, untangling adverse events, and an end to cholera vaccine shortages

Key Points

• To summarize recent developments related to vaccine regulations and cholera vaccine availability.
• Overview of recent news in the vaccine industry.
• Analysis of regulatory changes affecting vaccine approvals.
• Discussion on the implications of adverse events on vaccine supply.
• Highlighting regulatory reversals affecting vaccine timelines.
• Discussing advances in personalized mRNA cancer vaccines.
• Emphasizing ongoing shortages of cholera vaccines.

Abstract